Oral brincidofovir decreases the incidence of HHV-6B viremia after allogeneic HCT

Human herpesvirus 6B (HHV-6B) frequently reactivates after allogeneic hematopoietic cell transplantation (HCT). There are no randomized studies of antiviral treatments to prevent HHV-6B reactivation. Brincidofovir has high in vitro activity against HHV-6B and other DNA viruses, but its in vivo activ...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood
Egile Nagusiak: Hill, Joshua A., Nichols, W. Garrett, Marty, Francisco M., Papanicolaou, Genovefa A., Brundage, Thomas M., Lanier, Randall, Zerr, Danielle M., Boeckh, Michael J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2020
Gaiak:
Clinical Trials and Observations
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7180083/
https://ncbi.nlm.nih.gov/pubmed/32076716
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019004315
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak